DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
News | 04. 22. 2013
Jayson Punwani will moderate a discussion on Impact Investing at BIO International Convention 2013 in Chicago.
